See more : Neurones S.A. (0GX2.L) Income Statement Analysis – Financial Results
Complete financial analysis of Rite Aid Corporation (RAD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rite Aid Corporation, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Charles Stanley Group PLC (CAY.L) Income Statement Analysis – Financial Results
- Enzymatica AB (publ) (ENZY.ST) Income Statement Analysis – Financial Results
- FB Financial Corporation (FBK) Income Statement Analysis – Financial Results
- Hangzhou Lion Electronics Co.,Ltd (605358.SS) Income Statement Analysis – Financial Results
- SD ENTERTAINMENT,Inc. (4650.T) Income Statement Analysis – Financial Results
Rite Aid Corporation (RAD)
About Rite Aid Corporation
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.09B | 24.57B | 24.04B | 21.93B | 21.64B | 21.53B | 22.93B | 30.74B | 26.53B | 25.53B | 25.39B | 26.12B | 25.21B | 25.67B | 26.29B | 24.33B | 17.51B | 17.27B | 16.82B | 16.60B | 15.80B | 15.17B | 14.52B | 14.68B | 12.73B | 11.38B | 6.97B | 5.45B | 4.53B | 4.06B | 4.09B | 3.75B | 3.45B | 3.17B | 2.87B | 2.49B | 1.76B | 1.56B |
| Cost of Revenue | 19.29B | 19.46B | 19.34B | 17.20B | 16.96B | 16.75B | 17.86B | 22.91B | 18.95B | 18.20B | 18.07B | 19.33B | 18.52B | 18.85B | 19.25B | 17.69B | 12.79B | 12.57B | 12.61B | 12.57B | 12.11B | 11.74B | 10.77B | 10.97B | 9.14B | 8.02B | 4.94B | 3.90B | 3.23B | 2.87B | 2.89B | 2.63B | 2.39B | 2.20B | 1.98B | 1.73B | 1.21B | 1.08B |
| Gross Profit | 4.80B | 5.11B | 4.70B | 4.73B | 4.68B | 4.78B | 5.06B | 7.83B | 7.58B | 7.32B | 7.32B | 6.79B | 6.69B | 6.82B | 7.04B | 6.64B | 4.72B | 4.70B | 4.21B | 4.03B | 3.69B | 3.43B | 3.75B | 3.71B | 3.59B | 3.36B | 2.03B | 1.55B | 1.30B | 1.18B | 1.19B | 1.12B | 1.05B | 973.00M | 885.00M | 756.30M | 546.80M | 485.50M |
| Gross Profit Ratio | 19.94% | 20.78% | 19.57% | 21.56% | 21.61% | 22.20% | 22.09% | 25.46% | 28.56% | 28.69% | 28.82% | 26.01% | 26.54% | 26.58% | 26.76% | 27.28% | 26.94% | 27.21% | 25.02% | 24.29% | 23.36% | 22.60% | 25.83% | 25.29% | 28.23% | 29.52% | 29.06% | 28.41% | 28.77% | 29.18% | 29.22% | 29.83% | 30.55% | 30.67% | 30.85% | 30.42% | 31.13% | 31.04% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.60B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 3.37B | 3.46B | 3.71B | 2.64B | 2.39B | 1.43B | 1.10B | 932.20M | 1.01B | 847.70M | 781.90M | 732.90M | 700.10M | 613.60M | 506.50M | 346.60M | 304.50M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 483.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 352.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.58B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 4.20B | 4.65B | 4.21B | 2.94B | 2.67B | 1.60B | 1.22B | 1.03B | 1.11B | 946.00M | 875.40M | 826.20M | 784.50M | 690.40M | 567.50M | 390.90M | 341.70M |
| Cost & Expenses | 24.19B | 24.50B | 24.00B | 21.79B | 21.56B | 21.40B | 22.64B | 29.92B | 25.65B | 24.76B | 24.67B | 25.86B | 24.98B | 25.43B | 26.24B | 24.06B | 17.16B | 16.88B | 16.37B | 16.22B | 15.52B | 15.94B | 15.42B | 15.18B | 12.08B | 10.69B | 6.55B | 5.12B | 4.26B | 3.98B | 3.84B | 3.51B | 3.22B | 2.98B | 2.67B | 2.30B | 1.60B | 1.42B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M | 202.77M | 200.07M | 449.57M | 397.61M | 424.59M | 515.42M | 529.26M | 547.58M | 515.76M | 477.63M | 449.60M | 275.22M | 277.02M | 294.87M | 313.50M | 396.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M | 386.06M | 407.37M | 509.21M | 416.63M | 403.74M | 414.11M | 440.58M | 505.55M | 534.24M | 586.21M | 472.47M | 270.31M | 249.76M | 246.74M | 264.29M | 285.33M | 349.84M | 384.07M | 501.00M | 302.60M | 274.20M | 168.10M | 118.70M | 98.60M | 95.70M | 98.30M | 93.50M | 93.30M | 84.40M | 76.80M | 61.00M | 44.30M | 37.20M |
| EBITDA | 178.44M | 368.31M | 374.26M | 467.70M | 441.86M | 514.90M | 695.08M | 1.32B | 1.30B | 1.17B | 1.45B | 702.51M | 762.44M | 778.10M | -2.91B | -1.08B | 834.33M | 918.46M | 718.57M | 686.98M | 681.40M | -17.56M | -11.40M | 95.52M | 1.21B | 964.00M | 659.70M | 443.20M | 372.40M | 170.10M | 345.90M | 336.30M | 320.40M | 272.90M | 268.30M | 247.40M | 195.40M | 177.00M |
| EBITDA Ratio | 0.74% | 1.50% | 1.56% | 2.13% | 2.04% | 2.39% | 3.03% | 4.30% | 4.89% | 4.57% | 4.46% | 2.69% | 3.02% | 3.03% | 10.62% | 3.45% | 3.84% | 4.13% | 4.27% | 4.14% | 4.31% | -0.12% | -0.08% | 0.65% | 9.52% | 8.47% | 9.46% | 8.14% | 8.21% | 4.19% | 8.47% | 8.97% | 9.29% | 8.60% | 9.35% | 9.95% | 11.12% | 11.32% |
| Operating Income | -98.15M | 72.62M | 47.14M | 139.42M | 83.98M | 128.84M | 287.71M | 812.91M | 881.09M | 762.57M | 717.51M | 261.92M | 256.90M | 243.86M | 2.21B | 366.78M | 402.48M | 463.10M | 471.83M | 422.69M | 396.07M | -367.40M | -395.47M | -405.47M | 909.00M | 689.80M | 491.60M | 324.50M | 273.80M | 74.40M | 247.60M | 242.80M | 227.10M | 188.50M | 191.50M | 186.40M | 151.10M | 139.80M |
| Operating Income Ratio | -0.41% | 0.30% | 0.20% | 0.64% | 0.39% | 0.60% | 1.25% | 2.64% | 3.32% | 2.99% | 2.83% | 1.00% | 1.02% | 0.95% | 8.39% | 1.51% | 2.30% | 2.68% | 2.81% | 2.55% | 2.51% | -2.42% | -2.72% | -2.76% | 7.14% | 6.06% | 7.05% | 5.96% | 6.04% | 1.83% | 6.06% | 6.48% | 6.59% | 5.94% | 6.68% | 7.50% | 8.60% | 8.94% |
| Total Other Income/Expenses | -658.26M | -614.88M | -20.16M | -221.03M | -673.45M | -172.39M | -239.19M | -534.51M | -454.27M | -512.35M | -710.01M | -261.89M | 9.84M | 26.76M | -2.63B | -544.94M | -388.90M | -419.85M | -168.47M | -403.12M | -167.64M | -405.44M | -887.34M | -710.27M | -709.40M | -159.80M | -164.60M | -68.30M | -42.30M | -28.70M | -33.00M | -40.80M | -52.40M | -54.70M | -40.30M | -32.20M | -18.10M | -11.90M |
| Income Before Tax | -756.40M | -542.26M | -120.23M | -81.61M | -589.48M | -43.55M | 48.52M | 278.40M | 426.82M | 250.22M | 7.51M | -392.26M | -545.58M | -479.92M | -2.58B | -273.50M | 13.58M | 43.25M | 134.01M | 34.52M | -167.64M | -772.84M | -1.28B | -1.12B | 199.60M | 530.00M | 258.90M | 256.20M | 231.50M | 45.70M | 214.60M | 202.00M | 174.70M | 133.80M | 154.30M | 156.60M | 137.80M | 127.90M |
| Income Before Tax Ratio | -3.14% | -2.21% | -0.50% | -0.37% | -2.72% | -0.20% | 0.21% | 0.91% | 1.61% | 0.98% | 0.03% | -1.50% | -2.16% | -1.87% | -9.82% | -1.12% | 0.08% | 0.25% | 0.80% | 0.21% | -1.06% | -5.09% | -8.84% | -7.60% | 1.57% | 4.66% | 3.71% | 4.70% | 5.11% | 1.13% | 5.25% | 5.39% | 5.07% | 4.22% | 5.38% | 6.30% | 7.84% | 8.18% |
| Income Tax Expense | -6.47M | -3.78M | -20.16M | 387.61M | 77.48M | 305.99M | 44.44M | 112.94M | -1.68B | 804.00K | -110.60M | -23.69M | 9.84M | 26.76M | 329.26M | 802.70M | -13.24M | -1.23B | -168.47M | -48.80M | -41.94M | -11.75M | 148.96M | 8.00K | 55.90M | 213.60M | 98.40M | 97.30M | 90.20M | 19.50M | 82.20M | 78.00M | 67.40M | 51.90M | 59.10M | 62.80M | 59.80M | 60.00M |
| Net Income | -749.94M | -538.48M | -100.07M | -469.22M | -422.21M | 943.47M | 4.05M | 165.47M | 2.11B | 249.41M | 118.11M | -368.57M | -555.42M | -506.68M | -2.92B | -1.08B | 26.83M | 1.27B | 302.48M | 83.31M | -112.08M | -827.68M | -1.59B | -1.14B | 143.70M | 316.40M | 115.30M | 158.90M | 141.30M | 9.30M | 132.40M | 124.00M | 107.30M | 102.10M | 95.20M | 140.90M | 78.00M | 62.50M |
| Net Income Ratio | -3.11% | -2.19% | -0.42% | -2.14% | -1.95% | 4.38% | 0.02% | 0.54% | 7.95% | 0.98% | 0.47% | -1.41% | -2.20% | -1.97% | -11.09% | -4.44% | 0.15% | 7.37% | 1.80% | 0.50% | -0.71% | -5.46% | -10.95% | -7.79% | 1.13% | 2.78% | 1.65% | 2.92% | 3.12% | 0.23% | 3.24% | 3.31% | 3.11% | 3.22% | 3.32% | 5.67% | 4.44% | 4.00% |
| EPS | -13.71 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 43.40 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 47.20 | 10.05 | 2.27 | -4.34 | -35.03 | -111.20 | -88.19 | -35.80 | -14.80 | 6.30 | 9.50 | 16.70 | 0.90 | 7.50 | 7.10 | 3.25 | 3.10 | 2.85 | 4.30 | 2.40 | 1.90 |
| EPS Diluted | -13.64 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 41.60 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 37.80 | 8.25 | 2.23 | -4.34 | -35.03 | -95.73 | -88.19 | -35.80 | -14.80 | 6.30 | 9.20 | 16.70 | 0.90 | 7.30 | 7.00 | 3.25 | 3.05 | 2.85 | 4.30 | 2.40 | 1.90 |
| Weighted Avg Shares Out | 54.68M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 52.22M | 51.22M | 48.56M | 46.11M | 44.48M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 26.20M | 26.98M | 20.67M | 25.85M | 23.62M | 14.29M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
| Weighted Avg Shares Out (Dil) | 54.99M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 53.04M | 52.12M | 50.89M | 48.95M | 45.36M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 33.83M | 31.70M | 26.29M | 25.85M | 23.62M | 16.60M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
Top 5 Defensive Stocks That Could Blast Off This Quarter - Dollar Tree (NASDAQ:DLTR), Eastside Distilling (NASDAQ:EAST)
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Rite Aid stock is experiencing extreme turbulence: Here's why
Shares of Rite Aid were slightly lower Monday after soaring more than 20% higher in morning trading.
Why Are Stocks Up Today?
Stocks are up today and investors wondering why need look no further as we have the answer to that question! It looks like stocks are up today as investors anticipate positive news later this week.
RAD Stock Alert: Will Rite Aid Be the Next Big Short Squeeze?
Rite Aid (NYSE :RAD ) stock is advancing 2% in morning trading as of this writing. This comes after RAD stock plunged some 50% on Friday.
Why Is Rite Aid (RAD) Stock Down Today?
Rite Aid (NYSE: RAD ) stock is falling on Monday following reports that the pharmaceutical company is preparing to file for bankruptcy. According to these reports, Rite Aid is getting ready to file for bankruptcy in the near future.
3M shares climb on lawsuit settlement update, while Rite Aid drops on bankruptcy reports and other moving shares
Shares of 3M Co. MMM, +0.46% rose 4.6% in premarket trading after The Wall Street Journal reported that the multinational conglomerate was nearing agreement on a $5.5 billion plan to settle more than 300,000 lawsuits over defective military earplugs.
Twinkies and Snoballs parent Hostess scores best stock day ever on deal buzz; Rite Aid suffers its worst
A pair of classic American brands had opposite days Friday as shares of one soared to their best day ever on reports of a possible sale, while the other's stock suffered its worst performance on record after a report of...
RAD Stock Alert: Rite Aid Plunges on the Brink of Bankruptcy
What a day it's been for shareholders in Rite Aid (NYSE: RAD ). Shares of RAD stock sank more than 50% in today's session as investors priced in some rather bleak news.
Rite Aid prepares to file for bankruptcy: report
Rite Aid, one of the biggest pharmacy chains in the country, is preparing to file for Chapter 11 bankruptcy protection in coming weeks, according to a new report.
Rite Aid's stock drops more than 50% on pending chapter 11 bankruptcy: WSJ
Rite Aid Corp. RAD, -52.78% shares dropped Friday following a report that the drugstore chain was filing for chapter 11 bankruptcy protection because of opioid lawsuits. Rite Aid shares dropped more than 50% to an intraday low of 66 cents...
Source: https://incomestatements.info
Category: Stock Reports